Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 06:09:28 - browse：7511

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Cell therapy fails to slow type 1 diabetes, but safety is established

focus

WSS

Medical bills so high, Medicare adding extra digits to claim forms

What to know about the judge who will handle the Trump case

Why rehabilitation engineers need to center patients in their research

Bird flu in milk supply is likely coming from asymptomatic cows

Cancer researcher Catriona Jamieson is sending tumors into space

After traumatic brain injury, life support decisions can use more time

explore

Wikipedia

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Treatments for cramps don't cut it. Why aren't there better options?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Illinois Supreme Court finds assault weapons ban constitutional

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth financials solid despite Change Healthcare cyberattack

Medicare details structure of new drug price negotiation program

FTC falls short on scrutinizing hospital mergers, study says

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Hospitals are dialing back on venture capital investing

explore

Close Medicare's dangerous gaps in addiction treatment coverage

Medical bills so high, Medicare adding extra digits to claim forms

After Optum profits sink, UnitedHealth makes changes

Close Medicare's dangerous gaps in addiction treatment coverage

Cancer researcher Catriona Jamieson is sending tumors into space

Judge sides with young activists in first

leisure time

focus

focus

leisure time